To reach the next value inflection
LicenseRx asset brief
Vascularized Thyroid-on-a-Chip for Personalized Drug Screening and Disease Modeling
Probability of Success
27% · grade B · Medium data confidence
Model PoS 27% (grade B, medium data confidence). Strongest signals: Data maturity, Indication pull. Biggest drag: Licensing readiness.
Data maturity (22%)
67
Preclinical; efficacy signal, human data, clinical reference.
IP position (16%)
72
Patent filed/pending -- prosecution ongoing.
Modality feasibility (14%)
80
Diagnostic/biomarker -- can monetize via service before full approval.
Indication pull (14%)
84
Oncology, Cardiometabolic -- active buyer appetite. Public text flags unmet need.
Competitive whitespace (12%)
78
Under-served segment; crowded oncology field; multi-modal differentiation.
Translational evidence (12%)
78
Public evidence mentions: clinical, efficacy, human, patient.
Licensing readiness (10%)
94
Listed as available for licensing; established tech-transfer office; 1 public source link(s).
Unlock the full strategic deep dive
Cost to the next milestone, decisive data, relevant articles, and the partner-ready development plan for this asset.
View Operator access See what's included →